Arriello Arriello
  • Home
  • Company
    • About Us
    • Our Team
    • Customer Experience
    • Client Testimonials
    • News
  • Resource Library
    • Guides and eBooks
    • Brochures
    • Case Studies
    • Webinars
    • Videos
    • Press Coverage
  • Career
    • Opportunities
    • Life at Arriello
    • Women Leaders
    • Employee Stories
  • Contact
  • Submit RFI/RFP
  • Pharmacovigilance
  • Regulatory Affairs
  • Auditing & QA
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech Medical Cannabis
Pharmacovigilance Overview
Clinical Safety Overview
Quality Management Overview
QPPV
  • QPPV Services
  • EudraVigilance
  • SPOR
  • PSMF
Safety Data Management
  • SAE & SUSAR Management
  • ART 57 (xEVMPD)
  • ICSR Case Management
  • Literature Monitoring
Signal & Benefit-Risk
  • Signal Detection & Management
  • Benefit-Risk Management - RMP, REMS
  • Drug Safety Physician Service
Medical Writing
  • Aggregate Reports
Pharmacovigilance IT Systems
  • Drug Safety Database
Clinical Safety
  • Drug Safety & Reporting Training
  • Responsible Person Services
  • Safety Management Plan
  • CT Documentation Development
Local Pharmacovigilance
  • LPPV & Local Safety Officer
  • Local ICSR Management
  • Local Literature Monitoring
Regulatory Intelligence
  • Regulatory Intelligence
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech Medical Cannabis
Regulatory Affairs Overview
Regulatory Consulting
  • Non-Clinical & Clinical Development Consultancy
  • Regulatory Strategy
  • Gap Analysis
  • Dossier Development
  • Scientific Advice – Protocol Assistance
  • Paediatric Investigation Plans
  • Orphan Drug Designation
  • SME Application
  • Regulatory Due Diligence
Regulatory Applications & Submissions
  • Clinical Trial Regulatory
  • Marketing Authorization Applications
  • Lifecycle Management
  • Marketing Authorization Transfers
  • CMC & Medical Writing
Regulatory Operations
  • Dossier Publishing
  • Artwork & Labeling
  • Linguistic Review & Translations
  • Readability & User Testing
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech Medical Cannabis
Quality Assurance and Auditing Overview
GVP Auditing
  • GVP Audit Program Management
  • GVP Independent Auditing
  • Remote & Desktop Auditing
  • Risk-based Questionnaires
Regulatory Inspections
  • Inspection Support
QA Management
  • Deviation & CAPA Management
  • Audit CAPA Management
  • Training
  • SOP Writing & Gap Analysis
  • KPI & Compliance Management
QA Consulting
  • QA Consulting
SDEA & PVA Management
  • SDEA & PVA Management
  • Vendor Management
  • Pharmacovigilance
  • Regulatory Affairs
  • Auditing & QA
  • Home
  • Company
    • About Us
    • Our Team
    • Customer Experience
    • Client Testimonials
    • News
  • Resource Library
    • Guides and eBooks
    • Brochures
    • Case Studies
    • Webinars
    • Videos
    • Press Coverage
  • Career
    • Opportunities
    • Life at Arriello
    • Women Leaders
    • Employee Stories
  • Contact
  • Submit RFI/RFP
Solutions by stage
Development Submission & Authorization Post-marketing
Specialized fields
Biotech Medical Cannabis
Main menu
QPPV
  • QPPV Services
  • EudraVigilance
  • SPOR
  • PSMF
Safety Data Management
  • SAE & SUSAR Management
  • ART 57 (xEVMPD)
  • ICSR Case Management
  • Literature Monitoring
Signal & Benefit-Risk
  • Signal Detection & Management
  • Benefit-Risk Management - RMP, REMS
  • Drug Safety Physician Service
Medical Writing
  • Aggregate Reports
Pharmacovigilance IT Systems
  • Drug Safety Database
Clinical Safety
  • Drug Safety & Reporting Training
  • Responsible Person Services
  • Safety Management Plan
  • CT Documentation Development
Local Pharmacovigilance
  • LPPV & Local Safety Officer
  • Local ICSR Management
  • Local Literature Monitoring
Regulatory Intelligence
  • Regulatory Intelligence
Pharmacovigilance Overview Clinical Safety Overview Quality Management Overview
Main menu
Regulatory Consulting
  • Non-Clinical & Clinical Development Consultancy
  • Regulatory Strategy
  • Gap Analysis
  • Dossier Development
  • Scientific Advice – Protocol Assistance
  • Paediatric Investigation Plans
  • Orphan Drug Designation
  • SME Application
  • Regulatory Due Diligence
Regulatory Applications & Submissions
  • Clinical Trial Regulatory
  • Marketing Authorization Applications
  • Lifecycle Management
  • Marketing Authorization Transfers
  • CMC & Medical Writing
Regulatory Operations
  • Dossier Publishing
  • Artwork & Labeling
  • Linguistic Review & Translations
  • Readability & User Testing
Regulatory Affairs Overview
Main menu
GVP Auditing
  • GVP Audit Program Management
  • GVP Independent Auditing
  • Remote & Desktop Auditing
  • Risk-based Questionnaires
Regulatory Inspections
  • Inspection Support
QA Management
  • Deviation & CAPA Management
  • Audit CAPA Management
  • Training
  • SOP Writing & Gap Analysis
  • KPI & Compliance Management
QA Consulting
  • QA Consulting
SDEA & PVA Management
  • SDEA & PVA Management
  • Vendor Management
Quality Assurance and Auditing Overview

Media.

Latest press coverage.

View all
Auditing & QA
Securing safety and quality: strengthening third party supplier controls.
Pharmacovigilance
Survey Reveals Overwhelmingly Positive Early Experiences of EMA’s New Clinical Trials Information System.
Pharmacovigilance
Survey reveals centralised clinical trials information system already driving European pharma innovation.

Our press contributors.

View all
Natalia Vlcek
Former EU QPPV.
All articles by this author
Monia Nica
Former Senior Regulatory Affairs Manager at Arriello.
All articles by this author
Dr. Eric Caugant
Safety Consultant and Advisor to Arriello.
All articles by this author
Cecilia Avram
Senior Regulatory Affairs Manager.
All articles by this author
Vanessa Fachada Oliveira
Former Pharmacovigilance Manager and EU QPPV.
All articles by this author

Vlogs, Videos and Webinars.

Latest LinkedIn posts.

Visit our LinkedIn profile
5 common (but unwarranted) fears inhibiting PV system change. If your current pharmacovigi...
5 common (but unwarranted) fears inhibiting PV system change. If your current pharmacovigi...
6 signs you need support with Quality Management. From issues arising because of an inspec...
6 signs you need support with Quality Management. From issues arising because of an inspec...
Arriello, your first choice for independent GVP Auditing. In this video Helen Lowe, our Di...
For all service inquiries, e-mail us at: solutions@arriello.com
Services
  • Pharmacovigilance
  • Clinical Safety
  • Quality Assurance and Auditing
  • Regulatory Affairs
  • Biotech
  • Medical Cannabis
Stages
  • Development
  • Submissions / Authorization
  • Post-Marketing
Quick links
  • Our Team
  • Client Testimonials
  • Guides and eBooks
  • Brochures
  • Webinars
  • Videos
  • Case Studies
  • Press Coverage
  • Press Contributors
ISO 9001 Certification
© Arriello Ireland Ltd. 2008–2022 | Adverse Events Reporting: safety@arriello.com | Company registration details | Privacy notice